

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.87755380 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.25550203 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.99591729 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.60832309 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.60832309 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.28554005 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28554005 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.93964426 |
| 9 | oxidative demethylation (GO:0070989) | 6.38911427 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.35372891 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.35372891 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.35372891 |
| 13 | drug metabolic process (GO:0017144) | 6.33876097 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22576672 |
| 15 | kynurenine metabolic process (GO:0070189) | 6.21765235 |
| 16 | * bile acid biosynthetic process (GO:0006699) | 6.01511537 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.96357442 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.92375276 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.77440894 |
| 20 | urea cycle (GO:0000050) | 5.73490008 |
| 21 | urea metabolic process (GO:0019627) | 5.73490008 |
| 22 | phenylpropanoid metabolic process (GO:0009698) | 5.73477385 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.56545673 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.49837066 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.47637376 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.44059153 |
| 27 | cysteine metabolic process (GO:0006534) | 5.40670240 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.40193048 |
| 29 | regulation of fibrinolysis (GO:0051917) | 5.40177499 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.35080850 |
| 31 | protein carboxylation (GO:0018214) | 5.35080850 |
| 32 | regulation of plasminogen activation (GO:0010755) | 5.28573806 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.27595438 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 5.16528690 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.11843923 |
| 36 | regulation of complement activation (GO:0030449) | 5.08606257 |
| 37 | * bile acid metabolic process (GO:0008206) | 5.05158470 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 5.04092875 |
| 39 | S-adenosylmethionine metabolic process (GO:0046500) | 4.97743851 |
| 40 | alkaloid metabolic process (GO:0009820) | 4.93557603 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.91600094 |
| 42 | ethanol metabolic process (GO:0006067) | 4.88969765 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.88726921 |
| 44 | negative regulation of blood coagulation (GO:0030195) | 4.81891486 |
| 45 | negative regulation of hemostasis (GO:1900047) | 4.81891486 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.81794751 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.79232929 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 4.79113871 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.70941546 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.70941546 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.70941546 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.68974439 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.68738342 |
| 54 | lysine metabolic process (GO:0006553) | 4.64583828 |
| 55 | lysine catabolic process (GO:0006554) | 4.64583828 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.60973673 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.60973673 |
| 58 | coenzyme catabolic process (GO:0009109) | 4.59508351 |
| 59 | glycine metabolic process (GO:0006544) | 4.50359432 |
| 60 | phospholipid efflux (GO:0033700) | 4.50114360 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.49453379 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 4.49444703 |
| 63 | acute-phase response (GO:0006953) | 4.47638242 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.44278572 |
| 65 | negative regulation of sterol transport (GO:0032372) | 4.44027935 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 4.44027935 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.40513668 |
| 68 | amine catabolic process (GO:0009310) | 4.40232321 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 4.40232321 |
| 70 | negative regulation of coagulation (GO:0050819) | 4.38442196 |
| 71 | negative regulation of wound healing (GO:0061045) | 4.34788082 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 4.32630346 |
| 73 | plasma lipoprotein particle clearance (GO:0034381) | 4.30865607 |
| 74 | negative regulation of protein activation cascade (GO:2000258) | 4.29478670 |
| 75 | glutamate metabolic process (GO:0006536) | 4.27890247 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.24043665 |
| 77 | regulation of humoral immune response (GO:0002920) | 4.21416363 |
| 78 | ethanol oxidation (GO:0006069) | 4.19930214 |
| 79 | cellular glucuronidation (GO:0052695) | 4.18103214 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 4.14621772 |
| 81 | cholesterol efflux (GO:0033344) | 4.14230467 |
| 82 | cellular modified amino acid catabolic process (GO:0042219) | 4.12023617 |
| 83 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.10030333 |
| 84 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.08108854 |
| 85 | hormone catabolic process (GO:0042447) | 4.07550395 |
| 86 | arginine metabolic process (GO:0006525) | 4.07239033 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 4.04731193 |
| 88 | positive regulation of hemostasis (GO:1900048) | 4.03045288 |
| 89 | positive regulation of blood coagulation (GO:0030194) | 4.03045288 |
| 90 | aldehyde catabolic process (GO:0046185) | 4.01436708 |
| 91 | fibrinolysis (GO:0042730) | 4.00367617 |
| 92 | intestinal cholesterol absorption (GO:0030299) | 3.98971540 |
| 93 | flavonoid metabolic process (GO:0009812) | 3.98044190 |
| 94 | cytolysis (GO:0019835) | 3.96569499 |
| 95 | heme transport (GO:0015886) | 3.96557384 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.92954634 |
| 97 | low-density lipoprotein particle remodeling (GO:0034374) | 3.90193553 |
| 98 | ketone body metabolic process (GO:1902224) | 3.89121369 |
| 99 | cofactor catabolic process (GO:0051187) | 3.87586830 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.85243109 |
| 101 | complement activation, classical pathway (GO:0006958) | 3.84846702 |
| 102 | steroid catabolic process (GO:0006706) | 3.82692704 |
| 103 | acetyl-CoA metabolic process (GO:0006084) | 3.80762011 |
| 104 | organic acid catabolic process (GO:0016054) | 3.78806751 |
| 105 | carboxylic acid catabolic process (GO:0046395) | 3.78806751 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78025781 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78025781 |
| 108 | complement activation (GO:0006956) | 3.77857399 |
| 109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73991098 |
| 110 | protein activation cascade (GO:0072376) | 3.73323700 |
| 111 | opsonization (GO:0008228) | 3.73161585 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.72064714 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 3.71695707 |
| 114 | negative regulation of lipase activity (GO:0060192) | 3.71581631 |
| 115 | positive regulation of coagulation (GO:0050820) | 3.71302985 |
| 116 | cholesterol homeostasis (GO:0042632) | 3.71297908 |
| 117 | uronic acid metabolic process (GO:0006063) | 3.71027355 |
| 118 | glucuronate metabolic process (GO:0019585) | 3.71027355 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.67249599 |
| 120 | NAD biosynthetic process (GO:0009435) | 3.65171703 |
| 121 | sterol homeostasis (GO:0055092) | 3.64982178 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.64877578 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 3.63490873 |
| 124 | drug catabolic process (GO:0042737) | 3.62989185 |
| 125 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.62002042 |
| 126 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.62002042 |
| 127 | negative regulation of complement activation (GO:0045916) | 3.61907584 |
| 128 | * xenobiotic metabolic process (GO:0006805) | 3.61593245 |
| 129 | polyketide metabolic process (GO:0030638) | 3.61251264 |
| 130 | doxorubicin metabolic process (GO:0044598) | 3.61251264 |
| 131 | daunorubicin metabolic process (GO:0044597) | 3.61251264 |
| 132 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.60885774 |
| 133 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.60885774 |
| 134 | plasma lipoprotein particle organization (GO:0071827) | 3.56961503 |
| 135 | response to mercury ion (GO:0046689) | 3.56356384 |
| 136 | regulation of lipoprotein particle clearance (GO:0010984) | 3.52069911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41412073 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.25340856 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.10411346 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51044473 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.36648231 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.03259436 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.82140086 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99394278 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.92165332 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07428508 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0254419 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99584891 |
| 13 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.93804564 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59914760 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56343374 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53609678 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45218959 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43148005 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39203324 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26961226 |
| 21 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.24719124 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21739330 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20184256 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17102167 |
| 25 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04952532 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01409918 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00297968 |
| 28 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.98962606 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98532549 |
| 30 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.98292336 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96698262 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96224532 |
| 33 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.95430765 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93321856 |
| 35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91832832 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91621125 |
| 37 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90084080 |
| 38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89801917 |
| 39 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.87992475 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86798911 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86793836 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85438111 |
| 43 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85129634 |
| 44 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84687914 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83760615 |
| 46 | NFYA_21822215_ChIP-Seq_K562_Human | 0.82996061 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82607025 |
| 48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82258986 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81376379 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81307380 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.81029401 |
| 52 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81027032 |
| 53 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.80900511 |
| 54 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.80864452 |
| 55 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78815052 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.78243270 |
| 57 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77602819 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76975855 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76875502 |
| 60 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76827205 |
| 61 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.75988724 |
| 62 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75151807 |
| 63 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.74900132 |
| 64 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74183864 |
| 65 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.73568604 |
| 66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73056211 |
| 67 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.72599746 |
| 68 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.72115105 |
| 69 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72064866 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71372401 |
| 71 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.70327050 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.68924184 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.68924184 |
| 74 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.68900229 |
| 75 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.68900229 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68637991 |
| 77 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68047940 |
| 78 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.67802794 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.66991715 |
| 80 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.66684659 |
| 81 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66169424 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65839296 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65730254 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65730254 |
| 85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64917296 |
| 86 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64646782 |
| 87 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.64456837 |
| 88 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.64456837 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64440011 |
| 90 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.64078342 |
| 91 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.63592000 |
| 92 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.63336525 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63242653 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63172756 |
| 95 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.62560004 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61979588 |
| 97 | NFYB_21822215_ChIP-Seq_K562_Human | 0.61976735 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.60782153 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60730934 |
| 100 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.60728320 |
| 101 | ERA_21632823_ChIP-Seq_H3396_Human | 0.60683266 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.60675955 |
| 103 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.60395911 |
| 104 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.59827087 |
| 105 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59482385 |
| 106 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56585022 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56229227 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.54672518 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53898862 |
| 110 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52491871 |
| 111 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52314312 |
| 112 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52230474 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51655375 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51561514 |
| 115 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51155037 |
| 116 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48573761 |
| 117 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.47312743 |
| 118 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47174862 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46801854 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46770786 |
| 121 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46405842 |
| 122 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46132457 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.45569745 |
| 124 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44991425 |
| 125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44248948 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43933475 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43406124 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43002219 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42914953 |
| 130 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42346310 |
| 131 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.41814589 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40670844 |
| 133 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40229201 |
| 134 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.39810244 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39734946 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39299352 |
| 137 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39064185 |
| 138 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39010723 |
| 139 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38655661 |
| 140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38387920 |
| 141 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38375344 |
| 142 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36722469 |
| 143 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.36713625 |
| 144 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36365336 |
| 145 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35516627 |
| 146 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34980696 |
| 147 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34806899 |
| 148 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33962149 |
| 149 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33868893 |
| 150 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33752570 |
| 151 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.32790277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.48789814 |
| 2 | MP0005360_urolithiasis | 7.59649616 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 6.38071477 |
| 4 | * MP0005365_abnormal_bile_salt | 6.11726994 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.04748043 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.35407565 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.63711744 |
| 8 | * MP0003252_abnormal_bile_duct | 3.63464638 |
| 9 | MP0009840_abnormal_foam_cell | 3.30045792 |
| 10 | MP0005083_abnormal_biliary_tract | 3.07325174 |
| 11 | MP0003195_calcinosis | 2.82293013 |
| 12 | MP0005332_abnormal_amino_acid | 2.80487020 |
| 13 | * MP0001666_abnormal_nutrient_absorption | 2.41651040 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.32087929 |
| 15 | * MP0000609_abnormal_liver_physiology | 2.17331985 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.12951415 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.12530513 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.05699193 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.87321402 |
| 20 | MP0001764_abnormal_homeostasis | 1.72178728 |
| 21 | MP0009697_abnormal_copulation | 1.60216141 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59529115 |
| 23 | * MP0003868_abnormal_feces_composition | 1.55591610 |
| 24 | MP0005451_abnormal_body_composition | 1.53524737 |
| 25 | MP0003011_delayed_dark_adaptation | 1.44983003 |
| 26 | MP0003186_abnormal_redox_activity | 1.28571405 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.26884594 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.22309454 |
| 29 | MP0000598_abnormal_liver_morphology | 1.19866192 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.19782878 |
| 31 | MP0005647_abnormal_sex_gland | 1.19580851 |
| 32 | MP0009764_decreased_sensitivity_to | 1.05506831 |
| 33 | MP0000604_amyloidosis | 1.04322873 |
| 34 | MP0009763_increased_sensitivity_to | 1.00764778 |
| 35 | MP0002254_reproductive_system_inflammat | 0.97953336 |
| 36 | MP0010368_abnormal_lymphatic_system | 0.97333169 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 0.91165698 |
| 38 | MP0008469_abnormal_protein_level | 0.89955131 |
| 39 | MP0005187_abnormal_penis_morphology | 0.86680979 |
| 40 | * MP0009642_abnormal_blood_homeostasis | 0.86474277 |
| 41 | MP0005408_hypopigmentation | 0.84655182 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 0.84205162 |
| 43 | MP0005376_homeostasis/metabolism_phenot | 0.82439941 |
| 44 | MP0002078_abnormal_glucose_homeostasis | 0.78678291 |
| 45 | MP0002876_abnormal_thyroid_physiology | 0.78270630 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 0.77998864 |
| 47 | MP0009765_abnormal_xenobiotic_induced | 0.76606153 |
| 48 | MP0005670_abnormal_white_adipose | 0.75931703 |
| 49 | MP0002282_abnormal_trachea_morphology | 0.75710725 |
| 50 | MP0003879_abnormal_hair_cell | 0.73778075 |
| 51 | MP0005220_abnormal_exocrine_pancreas | 0.73725759 |
| 52 | MP0004130_abnormal_muscle_cell | 0.71745064 |
| 53 | MP0002971_abnormal_brown_adipose | 0.70891487 |
| 54 | MP0005535_abnormal_body_temperature | 0.70031753 |
| 55 | MP0005334_abnormal_fat_pad | 0.69800772 |
| 56 | MP0001915_intracranial_hemorrhage | 0.69444856 |
| 57 | MP0005266_abnormal_metabolism | 0.67749247 |
| 58 | MP0003690_abnormal_glial_cell | 0.67092457 |
| 59 | MP0009053_abnormal_anal_canal | 0.63396635 |
| 60 | MP0003329_amyloid_beta_deposits | 0.62840236 |
| 61 | MP0000639_abnormal_adrenal_gland | 0.62129109 |
| 62 | MP0006035_abnormal_mitochondrial_morpho | 0.61871385 |
| 63 | MP0004381_abnormal_hair_follicle | 0.61846219 |
| 64 | MP0001756_abnormal_urination | 0.59214322 |
| 65 | MP0001661_extended_life_span | 0.58197580 |
| 66 | MP0005448_abnormal_energy_balance | 0.54601410 |
| 67 | MP0002822_catalepsy | 0.51300548 |
| 68 | MP0002249_abnormal_larynx_morphology | 0.49040261 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.48515660 |
| 70 | MP0002928_abnormal_bile_duct | 0.48207833 |
| 71 | MP0005395_other_phenotype | 0.46902382 |
| 72 | MP0003638_abnormal_response/metabolism_ | 0.45454093 |
| 73 | MP0003718_maternal_effect | 0.45199114 |
| 74 | MP0008874_decreased_physiological_sensi | 0.45148929 |
| 75 | MP0003724_increased_susceptibility_to | 0.44194528 |
| 76 | MP0008873_increased_physiological_sensi | 0.43781042 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.43429011 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.42917206 |
| 79 | MP0004142_abnormal_muscle_tone | 0.42857217 |
| 80 | MP0005166_decreased_susceptibility_to | 0.42165216 |
| 81 | MP0002837_dystrophic_cardiac_calcinosis | 0.41603568 |
| 82 | MP0003075_altered_response_to | 0.41110332 |
| 83 | MP0009785_altered_susceptibility_to | 0.40818694 |
| 84 | MP0003953_abnormal_hormone_level | 0.40212569 |
| 85 | MP0009384_cardiac_valve_regurgitation | 0.40198576 |
| 86 | MP0003436_decreased_susceptibility_to | 0.40043291 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.39607355 |
| 88 | MP0005248_abnormal_Harderian_gland | 0.39383650 |
| 89 | MP0000579_abnormal_nail_morphology | 0.39079146 |
| 90 | MP0002796_impaired_skin_barrier | 0.39071440 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.37121813 |
| 92 | MP0009672_abnormal_birth_weight | 0.36854315 |
| 93 | MP0006292_abnormal_olfactory_placode | 0.36001908 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.35148444 |
| 95 | MP0005023_abnormal_wound_healing | 0.34804675 |
| 96 | MP0008872_abnormal_physiological_respon | 0.34180924 |
| 97 | MP0006082_CNS_inflammation | 0.32724075 |
| 98 | MP0004883_abnormal_blood_vessel | 0.32405003 |
| 99 | MP0010386_abnormal_urinary_bladder | 0.32393712 |
| 100 | MP0009115_abnormal_fat_cell | 0.31981164 |
| 101 | MP0001243_abnormal_dermal_layer | 0.31679737 |
| 102 | MP0001853_heart_inflammation | 0.31579061 |
| 103 | MP0000249_abnormal_blood_vessel | 0.31469715 |
| 104 | MP0002970_abnormal_white_adipose | 0.30580636 |
| 105 | MP0002168_other_aberrant_phenotype | 0.29721995 |
| 106 | MP0003959_abnormal_lean_body | 0.29721618 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.27533204 |
| 108 | MP0001881_abnormal_mammary_gland | 0.27022693 |
| 109 | MP0000467_abnormal_esophagus_morphology | 0.26344075 |
| 110 | MP0005646_abnormal_pituitary_gland | 0.25663321 |
| 111 | MP0002060_abnormal_skin_morphology | 0.25509591 |
| 112 | MP0005551_abnormal_eye_electrophysiolog | 0.25295588 |
| 113 | MP0005164_abnormal_response_to | 0.25283236 |
| 114 | MP0002132_abnormal_respiratory_system | 0.25240279 |
| 115 | MP0004043_abnormal_pH_regulation | 0.24993355 |
| 116 | MP0002090_abnormal_vision | 0.24726403 |
| 117 | MP0000566_synostosis | 0.21749428 |
| 118 | MP0005197_abnormal_uvea_morphology | 0.20614910 |
| 119 | MP0005058_abnormal_lysosome_morphology | 0.19514400 |
| 120 | MP0001944_abnormal_pancreas_morphology | 0.18699073 |
| 121 | MP0001440_abnormal_grooming_behavior | 0.17329079 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.16514889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.54081483 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.39333121 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.32304356 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.74188589 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.56197736 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.35872355 |
| 7 | Xanthomatosis (HP:0000991) | 6.32424667 |
| 8 | Complement deficiency (HP:0004431) | 5.58702746 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.53165269 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.77343215 |
| 11 | Joint hemorrhage (HP:0005261) | 4.75257216 |
| 12 | Hyperammonemia (HP:0001987) | 4.62810971 |
| 13 | Epidermoid cyst (HP:0200040) | 4.60569807 |
| 14 | Hyperglycinemia (HP:0002154) | 4.48280705 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.35827330 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.34006444 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.32379489 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.30301876 |
| 19 | Ketosis (HP:0001946) | 4.26282172 |
| 20 | Fat malabsorption (HP:0002630) | 4.21739582 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.20663820 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.14678913 |
| 23 | Abnormality of complement system (HP:0005339) | 4.07942089 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.05615661 |
| 25 | Hyperglycinuria (HP:0003108) | 3.90526065 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.89466140 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.89466140 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.86523154 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.81167269 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77107964 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.68005635 |
| 32 | Nephritis (HP:0000123) | 3.57948702 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.50515238 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.48672748 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.41091040 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.33375602 |
| 37 | Steatorrhea (HP:0002570) | 3.23448036 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.09354049 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.08106147 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05754791 |
| 41 | Hypochromic microcytic anemia (HP:0004840) | 3.03499810 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.02213866 |
| 43 | Ketoacidosis (HP:0001993) | 2.97069842 |
| 44 | Myocardial infarction (HP:0001658) | 2.95900342 |
| 45 | Reduced antithrombin III activity (HP:0001976) | 2.86097465 |
| 46 | Spontaneous abortion (HP:0005268) | 2.85173098 |
| 47 | Skin nodule (HP:0200036) | 2.84652456 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.84119881 |
| 49 | Osteomalacia (HP:0002749) | 2.83884829 |
| 50 | Metabolic acidosis (HP:0001942) | 2.77450408 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.65370609 |
| 52 | Lethargy (HP:0001254) | 2.60751536 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60124270 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.60124270 |
| 55 | Fair hair (HP:0002286) | 2.59646349 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57591998 |
| 57 | Acanthocytosis (HP:0001927) | 2.53625613 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.50556634 |
| 59 | Gout (HP:0001997) | 2.50104898 |
| 60 | Spastic diplegia (HP:0001264) | 2.49615995 |
| 61 | Vascular calcification (HP:0004934) | 2.49472388 |
| 62 | Arthropathy (HP:0003040) | 2.45316305 |
| 63 | Neonatal onset (HP:0003623) | 2.44232158 |
| 64 | Cholelithiasis (HP:0001081) | 2.43959628 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 2.43860248 |
| 66 | Cholecystitis (HP:0001082) | 2.43860248 |
| 67 | Mitral stenosis (HP:0001718) | 2.42803842 |
| 68 | Cerebral edema (HP:0002181) | 2.42266638 |
| 69 | Hypoglycemic seizures (HP:0002173) | 2.40361803 |
| 70 | Purpura (HP:0000979) | 2.38043699 |
| 71 | Irritability (HP:0000737) | 2.35735926 |
| 72 | Hyperphosphaturia (HP:0003109) | 2.34909170 |
| 73 | Pulmonary embolism (HP:0002204) | 2.33258045 |
| 74 | Glycosuria (HP:0003076) | 2.29273328 |
| 75 | Abnormality of urine glucose concentration (HP:0011016) | 2.29273328 |
| 76 | Malnutrition (HP:0004395) | 2.25677543 |
| 77 | Amyloidosis (HP:0011034) | 2.25543594 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.24361913 |
| 79 | Glomerulonephritis (HP:0000099) | 2.22446952 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.21096859 |
| 81 | Brushfield spots (HP:0001088) | 2.19045579 |
| 82 | Neonatal hypoglycemia (HP:0001998) | 2.17680691 |
| 83 | Pancreatitis (HP:0001733) | 2.16642764 |
| 84 | Bile duct proliferation (HP:0001408) | 2.15166817 |
| 85 | Abnormal biliary tract physiology (HP:0012439) | 2.15166817 |
| 86 | Enlarged kidneys (HP:0000105) | 2.13423651 |
| 87 | Esophageal varix (HP:0002040) | 2.13144277 |
| 88 | Gingival bleeding (HP:0000225) | 2.10443504 |
| 89 | Menorrhagia (HP:0000132) | 2.07918425 |
| 90 | Vomiting (HP:0002013) | 2.06566920 |
| 91 | Abnormality of the gallbladder (HP:0005264) | 2.05987323 |
| 92 | Late onset (HP:0003584) | 2.05234041 |
| 93 | Opisthotonus (HP:0002179) | 2.03072610 |
| 94 | Thrombophlebitis (HP:0004418) | 2.01484626 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.00535340 |
| 96 | Generalized aminoaciduria (HP:0002909) | 1.99839862 |
| 97 | Rickets (HP:0002748) | 1.97114863 |
| 98 | Poikilocytosis (HP:0004447) | 1.94866826 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94384228 |
| 100 | Abnormal cartilage morphology (HP:0002763) | 1.90702256 |
| 101 | Renal cortical cysts (HP:0000803) | 1.89063528 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 1.86687931 |
| 103 | Elevated hepatic transaminases (HP:0002910) | 1.85329158 |
| 104 | Abnormal urine phosphate concentration (HP:0012599) | 1.84238039 |
| 105 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84230864 |
| 106 | Bifid scrotum (HP:0000048) | 1.83455738 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82906988 |
| 108 | Elevated alkaline phosphatase (HP:0003155) | 1.82735557 |
| 109 | Status epilepticus (HP:0002133) | 1.81111530 |
| 110 | Hypophosphatemic rickets (HP:0004912) | 1.80453235 |
| 111 | Generalized hypopigmentation of hair (HP:0011358) | 1.79973942 |
| 112 | Gangrene (HP:0100758) | 1.78815553 |
| 113 | Abnormality of the Achilles tendon (HP:0005109) | 1.78653320 |
| 114 | Joint swelling (HP:0001386) | 1.76997165 |
| 115 | Increased serum ferritin (HP:0003281) | 1.76355665 |
| 116 | Abnormality of proline metabolism (HP:0010907) | 1.76058106 |
| 117 | Hydroxyprolinuria (HP:0003080) | 1.76058106 |
| 118 | Alkalosis (HP:0001948) | 1.73543935 |
| 119 | Abnormality of vitamin metabolism (HP:0100508) | 1.73125599 |
| 120 | Hyperglycemia (HP:0003074) | 1.71549920 |
| 121 | Cerebral palsy (HP:0100021) | 1.70854432 |
| 122 | Increased mean platelet volume (HP:0011877) | 1.70313356 |
| 123 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.68596410 |
| 124 | Acute hepatic failure (HP:0006554) | 1.66470425 |
| 125 | Atrioventricular block (HP:0001678) | 1.64931985 |
| 126 | Abnormal platelet function (HP:0011869) | 1.57215740 |
| 127 | Impaired platelet aggregation (HP:0003540) | 1.57215740 |
| 128 | Retinal atrophy (HP:0001105) | 1.56515382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.19488424 |
| 2 | FGFR4 | 4.64202073 |
| 3 | ERN1 | 4.47939856 |
| 4 | SIK1 | 4.32798762 |
| 5 | ERBB4 | 3.16464694 |
| 6 | TAOK3 | 3.12120512 |
| 7 | INSRR | 2.95411659 |
| 8 | PIK3CA | 2.45948592 |
| 9 | WNK3 | 2.43541689 |
| 10 | MAP2K4 | 2.39267567 |
| 11 | NTRK3 | 2.26682936 |
| 12 | PKN2 | 2.16474619 |
| 13 | MST1R | 2.03835310 |
| 14 | MAPK11 | 1.98481447 |
| 15 | FLT3 | 1.90036493 |
| 16 | MAP4K2 | 1.78773910 |
| 17 | PIK3CG | 1.78474167 |
| 18 | TYK2 | 1.67805088 |
| 19 | TRIB3 | 1.66793528 |
| 20 | ADRBK2 | 1.65916468 |
| 21 | LATS1 | 1.64097927 |
| 22 | MAPKAPK3 | 1.53146292 |
| 23 | DAPK2 | 1.52931191 |
| 24 | ABL2 | 1.52724333 |
| 25 | PTK6 | 1.44770807 |
| 26 | CAMKK2 | 1.41649473 |
| 27 | NEK9 | 1.40078066 |
| 28 | TNK2 | 1.39023621 |
| 29 | NLK | 1.38898294 |
| 30 | FGFR2 | 1.38543703 |
| 31 | FRK | 1.31023782 |
| 32 | KDR | 1.29168945 |
| 33 | WNK4 | 1.26304357 |
| 34 | MAP3K12 | 1.25998778 |
| 35 | JAK2 | 1.24203559 |
| 36 | MAP3K7 | 1.23283814 |
| 37 | PRKACA | 1.19740643 |
| 38 | PRKG1 | 1.18093346 |
| 39 | PINK1 | 1.17830103 |
| 40 | MAP3K10 | 1.14137966 |
| 41 | ERBB2 | 1.10880347 |
| 42 | PRKAA2 | 1.10783057 |
| 43 | TBK1 | 1.07790630 |
| 44 | MAPK15 | 1.07772361 |
| 45 | GRK6 | 1.06611500 |
| 46 | FER | 1.05272671 |
| 47 | JAK1 | 1.02040202 |
| 48 | MAP2K3 | 1.01641837 |
| 49 | MAPK4 | 0.99738128 |
| 50 | ACVR1B | 0.95653418 |
| 51 | MAP3K14 | 0.94441599 |
| 52 | PRKCZ | 0.94129288 |
| 53 | MYLK | 0.90936425 |
| 54 | TLK1 | 0.90741837 |
| 55 | CSNK1D | 0.89801514 |
| 56 | MUSK | 0.85487092 |
| 57 | EPHB1 | 0.84384396 |
| 58 | MAPK12 | 0.83475455 |
| 59 | MET | 0.83327097 |
| 60 | STK38L | 0.82593675 |
| 61 | CDK6 | 0.82106958 |
| 62 | PRKCE | 0.81568875 |
| 63 | TIE1 | 0.80433250 |
| 64 | STK16 | 0.77525650 |
| 65 | CAMK2G | 0.77441468 |
| 66 | PRKACG | 0.75657929 |
| 67 | PDK2 | 0.75377329 |
| 68 | MAP3K3 | 0.75294226 |
| 69 | EPHA3 | 0.74767306 |
| 70 | MAP3K11 | 0.74271700 |
| 71 | CAMKK1 | 0.74153438 |
| 72 | PRKCB | 0.73820653 |
| 73 | IRAK3 | 0.72922598 |
| 74 | DYRK1B | 0.72047142 |
| 75 | BMPR1B | 0.70726517 |
| 76 | SGK1 | 0.68310259 |
| 77 | GSK3A | 0.67445643 |
| 78 | BCR | 0.67247971 |
| 79 | CSK | 0.66928655 |
| 80 | PRKAA1 | 0.65841438 |
| 81 | RPS6KA3 | 0.65489039 |
| 82 | MAP2K6 | 0.64413686 |
| 83 | DYRK2 | 0.64162752 |
| 84 | SGK3 | 0.63893795 |
| 85 | CASK | 0.63373540 |
| 86 | CSNK1A1 | 0.62977298 |
| 87 | CAMK1D | 0.60599415 |
| 88 | MAPK7 | 0.60491055 |
| 89 | CSF1R | 0.57719857 |
| 90 | FGFR3 | 0.56254544 |
| 91 | PRKACB | 0.55722197 |
| 92 | RIPK1 | 0.55605586 |
| 93 | TGFBR2 | 0.55270344 |
| 94 | PDPK1 | 0.54859519 |
| 95 | PKN1 | 0.54601791 |
| 96 | CSNK1G1 | 0.54580694 |
| 97 | PTK2 | 0.54570054 |
| 98 | PRKCQ | 0.53536805 |
| 99 | IKBKE | 0.53144763 |
| 100 | CSNK1E | 0.52799557 |
| 101 | STK38 | 0.49670430 |
| 102 | CHUK | 0.47161861 |
| 103 | GRK1 | 0.46390094 |
| 104 | SGK2 | 0.45073788 |
| 105 | CSNK2A1 | 0.45055443 |
| 106 | IKBKB | 0.44528894 |
| 107 | ADRBK1 | 0.44193935 |
| 108 | IGF1R | 0.43909350 |
| 109 | TNIK | 0.43888333 |
| 110 | ICK | 0.43789931 |
| 111 | OXSR1 | 0.43538433 |
| 112 | PRKCG | 0.42311301 |
| 113 | CDK4 | 0.41673872 |
| 114 | MAP2K1 | 0.41165934 |
| 115 | MAP3K13 | 0.40959624 |
| 116 | MAP3K5 | 0.40767025 |
| 117 | MAP3K2 | 0.40706773 |
| 118 | RET | 0.40380522 |
| 119 | TXK | 0.39952252 |
| 120 | EPHA4 | 0.38936859 |
| 121 | BRSK2 | 0.37489685 |
| 122 | ZAP70 | 0.36993489 |
| 123 | SRC | 0.36597417 |
| 124 | EGFR | 0.36410820 |
| 125 | MTOR | 0.35806802 |
| 126 | CAMK4 | 0.35111825 |
| 127 | CSNK1G2 | 0.34517189 |
| 128 | CSNK1G3 | 0.33962550 |
| 129 | PBK | 0.33805820 |
| 130 | TAOK2 | 0.33440448 |
| 131 | MAP3K6 | 0.33390194 |
| 132 | PDK1 | 0.32854688 |
| 133 | MAP3K1 | 0.32169580 |
| 134 | SGK223 | 0.31352400 |
| 135 | SGK494 | 0.31352400 |
| 136 | LATS2 | 0.30020582 |
| 137 | PRKCA | 0.25991252 |
| 138 | IRAK2 | 0.25666177 |
| 139 | CSNK1A1L | 0.24843180 |
| 140 | BMX | 0.23136891 |
| 141 | IRAK1 | 0.23116280 |
| 142 | PAK3 | 0.22160246 |
| 143 | ABL1 | 0.22067286 |
| 144 | MAP2K2 | 0.20205279 |
| 145 | AKT3 | 0.19343706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.60058081 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49291977 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39893489 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26954949 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08425115 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76322413 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73685412 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.72136300 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66476959 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.59102294 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55007443 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42091583 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18904761 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18571675 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.15414923 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05656048 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94565855 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90620322 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88002393 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87644552 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85706418 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85200922 |
| 23 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82985386 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74827560 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73036271 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72095909 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69143183 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68296068 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67311641 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67286229 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61725368 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57443007 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56176775 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52740344 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50112348 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48788120 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46298613 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42321374 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38528259 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36333077 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35984589 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26025288 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25534909 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21430178 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20496357 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.17701544 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14175480 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13185360 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12511467 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04298718 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00556620 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99123242 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97134667 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95302357 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93394655 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87719119 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83196224 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.82422897 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80226887 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76876849 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70323837 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65712525 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64557521 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55910876 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55612728 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.46618908 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46570108 |
| 68 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45769917 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36462182 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26030365 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25448000 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22932111 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.22836300 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22423248 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.21302600 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19490839 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18798999 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16494625 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10777785 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.04824070 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01677775 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2388983 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2373680 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | -0.2360909 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2346631 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2256872 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2245066 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2239085 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2137653 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | -0.2136668 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2073243 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1938455 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1928526 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1884259 |
| 95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1769521 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1762727 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1603679 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1600901 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1550642 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1405156 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1330680 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1266847 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1241272 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1194101 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1019346 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0950866 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0892075 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0853841 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0738752 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | -0.0474935 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0449387 |

